Team Type: Executive Management Team

Dr. Setareh Shamsili has taken the helm of Coretag at the combined role of CEO and CMO, since April 2024. A seasoned oncology drug development veteran, Setareh brings more than 28 years of clinical oncology and drug development expertise, at key and executive/C-suite levels, to Coretag. Dr. Shamsili has been instrumental both strategically and operationally,… Continue reading Setareh Shamsili

Markwin Maring has over 35 years of experience as an entrepreneur and investor in private equity and public companies, with a focus on life sciences, medtech, financial services, and software development. After a career in marketing and communications, Maring co- founded the MeesPierson Informal Opportunity Fund in 2000 in partnership with MeesPierson Private Bank, followed… Continue reading Markwin Maring

Dr. Karen J. Williams is an innovative and dynamic leader with over three decades of experience in clinical research and drug development within the pharmaceutical and CRO industries. Her exceptional expertise encompasses oncology clinical research, business development, and strategic planning. Dr. Williams has personally managed more than 100 oncology clinical trials, spanning phases I to… Continue reading Karen Williams

As a scientist Ermond van Beek has an extensive experience in the executing of in-vivo experiments and animal testing with a focus on Near Infrared Imaging. In 2011, while conducting contract research for Coretag, it was Van Beek who discovered the necrosis-binding properties of cyanines. This discovery laid the groundwork for the development of Coretag’s… Continue reading Ermond van Beek

Dr. Bob Seevers has over 40 years of experience in the pharmaceutical research and development. His experience includes serving as an FDA reviewer/team leader, clinical investigator, and working in industry. After more than a decade in Nuclear Medicine, Bob spent 8 years with FDA, followed by 16 years with Eli Lilly and Company in Quality… Continue reading Bob Seevers